SCHEMBL170853

SCHEMBL170853

CCCCCCCCCCCCCCCCC(CC(O)CO)C(=O)OCC(O)CO

nearest known ligand 0.58

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.58
DUSP3 P51452 1/20 0.58
MEN1 O00255 1/20 0.58
KMT2A Q03164 1/20 0.58
LMNA P02545 1/20 0.58
DGKA P23743 1/20 0.50
USP2 O75604 1/20 0.47
FAAH O00519 4/20 0.45
ENPP2 Q13822 4/20 0.42
TRPV1 Q8NER1 1/20 0.42
LPAR6 P43657 1/20 0.41
LPAR1 Q92633 1/20 0.41
LPAR4 Q99677 1/20 0.41
LPAR5 Q9H1C0 1/20 0.41
LPAR2 Q9HBW0 1/20 0.41
LPAR3 Q9UBY5 1/20 0.41
GPR84 Q9NQS5 3/20 0.41
CA2 P00918 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28211898 1.00 KDM4E (0.58) KDM4EDUSP3MEN1KMT2ALMNA
SCHEMBL27112640 0.95 KMT2A (0.56) KDM4EDUSP3MEN1KMT2ALMNA
SCHEMBL29016126 0.92 KDM4E (0.63) KDM4EDUSP3MEN1KMT2ALMNA
SCHEMBL29118717 0.92 KDM4E (0.63) KDM4EDUSP3MEN1KMT2ALMNA
SCHEMBL28752404 0.92 KDM4E (0.63) KDM4EDUSP3MEN1KMT2ALMNA
SCHEMBL14778640 0.92 KDM4E (0.63) KDM4EDUSP3MEN1KMT2ALMNA
SCHEMBL252664 0.92 KDM4E (0.63) KDM4EDUSP3MEN1KMT2ALMNA
SCHEMBL21617316 0.92 KDM4E (0.63) KDM4EDUSP3MEN1KMT2ALMNA
SCHEMBL9173378 0.92 KDM4E (0.63) KDM4EDUSP3MEN1KMT2ALMNA
SCHEMBL21419884 0.92 KDM4E (0.63) KDM4EDUSP3MEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12576018-B2 Active agents for skin and hair care with sensory modifying properties SYMRISE AG (DE) 2026-03-17 US claimed
US-20250302033-A1 SOLUTIONS AND METHODS FOR FORMING AN EXOGENOUS FLEXIBLE FILM ON A PLANT AND PLANTS INCLUDING THE EXOGENOUS FLEXIBLE FILM Cultiva, LLC 2025-10-02 US claimed
US-12349674-B2 Solutions and methods for forming an exogenous flexible film on a plant and plants including the exogenous flexible film Cultiva, LLC (US) 2025-07-08 US claimed
US-20230354802-A1 SOLUTIONS AND METHODS FOR FORMING AN EXOGENOUS FLEXIBLE FILM ON A PLANT AND PLANTS INCLUDING THE EXOGENOUS FLEXIBLE FILM Cultiva, LLC 2023-11-09 US claimed
US-11737454-B2 Solutions and methods for forming an exogenous flexible film on a plant and plants including the exogenous flexible film Cultiva, LLC (US) 2023-08-29 US claimed
EP-4153321-A1 TOPICAL COMPOSITIONS, PROCESS OF LARGE-SCALE MANUFACTURE, AND METHOD OF USE Progeneron, LLC (US) 2023-03-29 EP claimed
WO-2022173184-A2 WASHING COMPOSITION CONTAINING OZONE WATER 전남대학교 산학협력단 2022-08-18 WO claimed
EP-4721723-A1 COSMETIC COMPOSITION HAVING EXCELLENT EFFICACY IN BLOCKING HARMFUL RAYS INCLUDING ULTRAVIOLET RAYS Kolmar Korea Co., Ltd. (KR) 2026-04-08 EP disclosed
EP-4687864-A1 PHARMACEUTICAL COMPOSITIONS FOR WOUND CARE Bio Protectant Technologies, Inc. (US) 2026-02-11 EP disclosed
EP-4663180-A1 SYNERGIC COMBINATION OF GREEN ASPALATHUS LINEARIS AND RED ASPALATHUS LINEARIS EXTRACTS FOR USE IN TREATING A SUN RADIATION-INDUCED DISEASE Industrial Farmaceutica Cantabria, S.A. (ES) 2025-12-17 EP disclosed
US-20250302033-A1 SOLUTIONS AND METHODS FOR FORMING AN EXOGENOUS FLEXIBLE FILM ON A PLANT AND PLANTS INCLUDING THE EXOGENOUS FLEXIBLE FILM Cultiva, LLC 2025-10-02 US disclosed
US-12349674-B2 Solutions and methods for forming an exogenous flexible film on a plant and plants including the exogenous flexible film Cultiva, LLC (US) 2025-07-08 US disclosed
EP-4447895-A1 COSMETIC AND/OR DERMATOLOGICAL COMPOSITION COMPRISING AT LEAST ONE MEROCYANINE AND AT LEAST ASCORBIC ACID AND/OR A DERIVATIVE THEREOF L'OREAL (FR) 2024-10-23 EP disclosed
EP-4093514-A1 AQUEOUS SUNCASE FORMULATION BASED ON SULFATED A CRYSTALLINE CELLULOSE SPF BOOSTER Dow Global Technologies LLC (US) 2022-11-30 EP disclosed
EP-4093371-A1 COSMETIC COMPOSITION Shiseido Company, Ltd. (JP) 2022-11-30 EP disclosed
WO-2022128536-A1 PROCESS FOR COATING KERATIN MATERIALS L'OREAL (FR) 2022-06-23 WO disclosed
WO-2022128534-A1 PROCESS FOR COATING KERATIN MATERIALS L'OREAL (FR) 2022-06-23 WO disclosed
WO-2022129403-A1 COMPOSITION COMPRISING AQUEOUS GELLING AGENTS, SURFACTANTS AND ASCORBIC ACID L'OREAL (FR) 2022-06-23 WO disclosed
US-20220110855-A1 TOPICAL BARRIER COMPOSITION FOR DERMAL APPLICATION DAY DORIS (US) 2022-04-14 US disclosed
US-20120058959-A1 TOPICAL ANTIVIRAL FORMULATIONS VIRAVERT LLC (US) 2012-03-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12576018-B2 Active agents for skin and hair care with sensory modifying properties SCD5, SMURF1, SGMS1 KDM4E 1676/4885DUSP3 1029/4885MEN1 4806/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.